InnoCare Pharma News

Nuocheng Jianhua: Legal Opinion of Shanghai Fangda Law Firm on the Public Solicitation of Authorized Voting Rights of Independent Non-Executive Directors of InnoCare Pharma Limited (InnoCare Pharma Limited)

Dec 17 11:00 ET

Nuochengjianhua: Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders (Extraordinary General Meeting of Shareholders) of Nuochengjianhua Pharmaceutical Co., Ltd.

Dec 17 11:00 ET

Nuocheng Jianhua: Legal Opinion of Shanghai Fangda Law Firm on the 2024 First Extraordinary General Meeting of Shareholders (Extraordinary General Meeting of Shareholders) of InnoCare Pharma Limited (InnoCare Pharma Limited)

Dec 17 11:00 ET

Legal Opinion of Shanghai Fangda Law Firm on the 2024 First Extraordinary General Meeting of Shareholders (Extraordinary General Meeting of Shareholders) of InnoCare Pharma Limited (InnoCare Pharma Limited)

Dec 17 11:00 ET

Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders (Extraordinary General Meeting of Shareholders) of Nuocheng Jianhua Pharmaceutical Co., Ltd.

Dec 17 11:00 ET

Notice of Nuochengjianhua Pharmaceutical Co., Ltd. on convening the 2024 First Extraordinary General Meeting of Shareholders (Extraordinary General Meeting of Shareholders)

Nov 28 11:00 ET

Meeting materials of the 2024 First Extraordinary General Meeting of Shareholders (Extraordinary General Meeting of Shareholders) of Nuochengjianhua Pharmaceutical Co., Ltd.

Nov 28 11:00 ET

Announcement on voluntary disclosure of ICP-488 phase II clinical trial results by Nuochengjianhua Pharmaceutical Co., Ltd.

Oct 9 12:00 ET

Nuochengjianhua: Announcement of Nuochengjianhua Pharmaceutical Co., Ltd. on the resignation of non-executive directors and independent non-executive directors and the change of members of the Board of Directors Special Committee

Sep 25 12:00 ET

Hong Kong Stock Announcement: List of Directors and Their Roles and Functions

Sep 25 12:00 ET

Announcement of Nuochengjianhua Pharmaceutical Co., Ltd. on the resignation of non-executive directors and independent non-executive directors and the change of members of the special committee of the board

Sep 25 12:00 ET

Announcement of Nuocheng Jianhua Pharmaceutical Co., Ltd. on changing the sponsor representative for continuous supervision

Sep 20 12:00 ET

Nuochengjianhua Pharmaceutical Co., Ltd. voluntarily disclosed the progress of clinical trials of obutinib

Sep 8 12:00 ET

InnoCare Pharma: Board of directors meeting date.

Aug 7 12:00 ET

InnoCare Pharma: Monthly securities change report.

Aug 5 12:00 ET

Innocare Pharmaceutical voluntarily discloses the announcement of the first dosing of ICP-332 trial subjects in the United States.

Jul 24 12:00 ET

InnoCare Pharma: Disclosure of the financial report on the following day.

Jul 19 12:00 ET

Innocare Pharmaceutical Co., Ltd.'s announcement regarding the "Improve Efficiency and Return to Increase Quality" action plan for 2024.

Jul 17 12:00 ET

InnoCare Pharma: Monthly securities change report.

Jul 4 12:00 ET

Announcement of the resolutions of the 2024 Shareholders' Annual Meeting of Innocare Pharmaceutical Co., Ltd.

Jun 27 12:00 ET